A nurse is providing care for a client who is scheduled for electroconvulsive therapy. Which of the following conditions should the nurse identify as an increased risk for complications?

Choice A reason: Discussing the prescription with the provider is critical, as amoxicillin, a penicillin derivative, is contraindicated in clients with penicillin allergies due to risk of anaphylaxis. This ensures patient safety by verifying or correcting the order, aligning with nursing advocacy and safety protocols, making it correct.
Choice B reason: Administering amoxicillin to a client with a penicillin allergy risks severe allergic reactions, including anaphylaxis, violating patient safety principles. Nurses must verify contraindicated orders before administration, making this action dangerous and incorrect in this scenario.
Choice C reason: Placing an incident report is premature, as no error has occurred yet. The nurse’s role is to prevent harm by addressing the contraindicated prescription proactively. This action does not resolve the issue and is inappropriate as the first step, making it incorrect.
Choice D reason: Calling the pharmacist for clarification is less direct than discussing with the provider, who issued the order. While pharmacists can provide guidance, the provider must confirm or change the prescription to ensure safety, making this action secondary and less effective.

Choice A reason: Penicillin, an antibiotic, has no known interactions with saw palmetto, a herbal supplement used for BPH. Saw palmetto affects prostate function, not antibiotic metabolism, so this combination is safe, making it an incorrect choice for an adverse interaction.
Choice B reason: Ipratropium, used for respiratory conditions, does not interact with saw palmetto, which targets prostate health. Their mechanisms are unrelated, and no significant drug-herb interaction exists, making this medication an incorrect choice for an adverse interaction with saw palmetto.
Choice C reason: Zolpidem, a sedative, has no documented interactions with saw palmetto. Saw palmetto’s effects on prostate tissue do not influence zolpidem’s central nervous system actions, so this combination is safe, making it incorrect for an adverse interaction.
Choice D reason: Finasteride, used for BPH, may interact with saw palmetto, as both reduce prostate size via similar mechanisms (inhibiting 5-alpha-reductase). Combined use can amplify effects or cause additive side effects, making this a potential adverse interaction, thus the correct choice.